Alpha 2.0
Login Register
» Authors » Xinrong Zhou

Xinrong Zhou

Explore the profile of Xinrong Zhou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 1100
Followers 0
Related Specialties
Endocrinology
General Medicine
Molecular Biology
Top 10 Co-Authors
Gang Yuan
Huiping Yuan
Zhelong Liu
Xuefeng Yu
Yan Yang
Junhui Xie
Tingting Du
Wentao He
Shuhong Hu
Qi Peng
Published In
Mol Med Rep
Cardiovasc Diabetol
Genome Announc
Front Public Health
J Med Virol
Affiliations
Soon will be listed here.
Recent Articles
11.
NHC-catalyzed formal [3 + 3] annulations of δ-acetoxy allenoates for the synthesis of 4-pyran derivatives
Shi B, Jin F, Lv Q, Zhou X, Liao Z, Yu C, et al.
Org Biomol Chem . 2023 Jul; 21(28):5775-5783. PMID: 37401568
Herein, an N-heterocyclic carbene (NHC) catalyzed formal [3 + 3] annulation of δ-acetoxy allenoates with 1C,3O-bisnucleophiles for the construction of 4-(fused)pyrans has been developed. This protocol provides a facile method...
12.
The prevalence, incidence, and persistence of self-reported visual impairment among Chinese population with diabetes mellitus: evaluation from a nationally representative survey, 2015-2018
Zhou Y, Wei J, Wang N, Chen Y, Fang C, Zhou M, et al.
Front Public Health . 2023 Jul; 11:978457. PMID: 37397768
Aims: Our aim was to investigate the prevalence, incidence, and persistence of visual impairment (VI) and their correlates among the Chinese population with diabetes mellitus (DM) over 3 years. Materials...
13.
Two long-lasting human monoclonal antibodies cross-react with monkeypox virus A35 antigen
Zhou B, Wang H, Cheng L, Zhao C, Zhou X, Liao X, et al.
Cell Discov . 2023 May; 9(1):50. PMID: 37230974
No abstract available.
14.
Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination
Wang M, Zhou B, Fan Q, Zhou X, Liao X, Lin J, et al.
Emerg Microbes Infect . 2022 Nov; 12(1):2151381. PMID: 36444724
With the ongoing COVID-19 pandemic and the emergence of various SARS-CoV-2 variants, a comprehensive evaluation of long-term efficacy of antibody response in convalescent individuals is urgently needed. Several longitudinal studies...
15.
Associations of lipid parameters with non-alcoholic fatty liver disease in type 2 diabetic patients according to obesity status and metabolic goal achievement
Zhu Z, Yang N, Fu H, Yuan G, Chen Y, Du T, et al.
Front Endocrinol (Lausanne) . 2022 Oct; 13:1002099. PMID: 36187115
Aims: Non-obese non-alcoholic fatty liver disease (NAFLD) phenotype has sparked interest and frequently occurred in type 2 diabetes mellitus (T2DM). Information on associations between lipid parameters and NAFLD in non-obese...
16.
Case report: Bilateral central serous chorioretinopathy-like abnormalities in a man with pulmonary arterial hypertension
Zhou X, Zhang J, Gu L, Zhou H, Zhang J
Front Med (Lausanne) . 2022 Aug; 9:983548. PMID: 35979218
Background: Pulmonary arterial hypertension (PAH) leads to progressive increases in pulmonary vascular resistance, right heart failure, and death if left untreated. Ocular complications secondary to PAH were less reported. In...
17.
A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice
Zhou B, Song S, Guo H, Zhou X, Fan Q, Liu W, et al.
J Med Virol . 2022 Apr; 94(8):3992-3997. PMID: 35474319
The SARS-CoV-2 vaccines have been widely used to build an immunologic barrier in the population against the COVID-19 pandemic. However, a newly emerging Omicron variant, including BA.1, BA.1.1, BA.2, and...
18.
Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209
Ju B, Zheng Q, Guo H, Fan Q, Li T, Song S, et al.
Cell Res . 2022 Mar; 32(5):491-494. PMID: 35260792
No abstract available.
19.
The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year
Zhang Z, Ju B, Zhou X, Cheng L, Wang H, Liao X, et al.
Emerg Microbes Infect . 2022 Feb; 11(1):753-756. PMID: 35184681
No abstract available.
20.
Circulating ANGPTL8 levels and risk of kidney function decline: Results from the 4C Study
Zou H, Xu Y, Meng X, Li D, Chen X, Du T, et al.
Cardiovasc Diabetol . 2021 Jun; 20(1):127. PMID: 34167540
Background: ANGPTL8, an important regulator of lipid metabolism, was recently proven to have additional intracellular and receptor-mediated functions. This study aimed to investigate circulating levels of ANGPTL8 and its potential...